Zivo Bioscience IncNASDAQ:ZIVONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE2.7600
- TODAY'S CHANGE (%)-0.0400 (-1.4286%)
- Bid / Lots2.5000/ 6
- Ask / Lots3.1800/ 1
- Open / Previous Close2.8000 / 2.8000
- Day Range
- 52 Week Range
- Volume10,657
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZIVO |
|---|---|---|
| 09:32 ET | 144 | 2.8 |
| 11:18 ET | 500 | 2.7999 |
| 11:48 ET | 300 | 2.64 |
| 11:50 ET | 900 | 2.7 |
| 12:03 ET | 400 | 2.71 |
| 12:24 ET | 5000 | 2.75 |
| 01:00 ET | 300 | 2.63 |
| 01:24 ET | 400 | 2.7 |
| 01:54 ET | 400 | 2.7 |
| 02:20 ET | 300 | 2.66 |
| 02:38 ET | 300 | 2.65 |
| 02:52 ET | 1262 | 2.69 |
| 02:56 ET | 180 | 2.76 |
Nov 29, 2022
BRIEF-Zivo Bioscience Has Received Notice Of Delisting From Nasdaq, from 4:43PM ET on Tuesday Nov 29, 2022 by Thomson Reuters
4:43PM ET on Tuesday Nov 29, 2022 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zivo Bioscience Inc | 26.0M | -2.7x | --- |
Real Brands Inc | 26.8M | -16.1x | --- |
Bit Origin Ltd | 25.0M | 241.8x | -60.20% |
Limitless X Holdings Inc | 23.6M | -1.6x | --- |
TDH Holdings Inc | 20.5M | -1.0x | --- |
Sow Good Inc | 17.0M | -2.0x | --- |
Company Information
Zivo Bioscience, Inc. is a research and development company. The Company is engaged in developing bioactive compounds derived from its algal culture, targeting human and animal diseases, such as poultry coccidiosis, bovine mastitis, human cholesterol, and canine osteoarthritis. Its algal biomass contains vitamin A, protein, iron, fatty acids, non-starch polysaccharides and other micronutrients. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, Algal biomass for animal feed and Biomass for supporting skin health / anti-aging. The Company is also engaged in licensing and selling natural bioactive ingredients derived from their algae cultures to animal, human and dietary supplement and medical food manufacturers.
Contact Information
- Headquarters
- 21 E. Long Lake Road, Suite 100BLOOMFIELD HILLS, MI, United States 48304
- Phone
- 248-452-9866
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Office, Director
- John Payne
- Chief Financial Officer
- Keith Marchiando
- Independent Director
- Alison Cornell
- Independent Director
- Christopher Maggiore
- Independent Director
- Nola Masterson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $26.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 9.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.01 |
EPS | $-1.04 |
Book Value | $0.64 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
